Lindsey Allen | Head of Investor Relations & Communications |
Justin Klee | Co-Chief Executive Officer |
Margaret Olinger | Chief Commercial Officer |
Jim Frates | Chief Financial Officer |
Josh Cohen | Co-Chief Executive Officer |
Corinne Jenkins | Goldman Sachs |
Geoff Meacham | Bank of America |
Michael DiFiore | Evercore |
Marc Goodman | Leerink Partners |
Graig Suvannavejh | Mizuho |
Ananda Ghosh | H.C. Wainwright |
Good afternoon. My name is Tom, and I will be your conference operator today. At this time I would like to welcome everyone to the Amylyx Pharmaceuticals Second Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode. After today’s presentation, there will be an opportunity to ask questions.